One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease

PURPOSE: The SANSIKA study evaluated the efficacy/safety of 0.1% (1 mg/mL) cyclosporine A cationic emulsion (CsA CE) for treating dry eye disease (DED) with severe keratitis. The double-masked phase demonstrated that CsA CE was effective in reducing corneal damage and ocular surface inflammation, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Baudouin, Christophe, de la Maza, Maite Sainz, Amrane, Mourad, Garrigue, Jean-Sébastien, Ismail, Dahlia, Figueiredo, Francisco C., Leonardi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380090/
https://www.ncbi.nlm.nih.gov/pubmed/28708219
http://dx.doi.org/10.5301/ejo.5001002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380090/
https://www.ncbi.nlm.nih.gov/pubmed/28708219
http://dx.doi.org/10.5301/ejo.5001002

Ejemplares similares